Abatacept in the treatment of polyarticular JIA: development, clinical utility, and place in therapy

References

• RavelliAMartiniAJuvenile idiopathic arthritisLancet2007369956376777817336654
   PubMed Web of Science ®Google Scholar
• WallaceCALevinsonJEJuvenile rheumatoid arthritis: Outcome and treatment for the 1990sRheum Dis Clin North Am19911748919051767079
   PubMed Web of Science ®Google Scholar
• PackhamJCHallMAPimmTJLong-term follow-up of 246 adults with JIA: Predictive factors for mood and painRheumatology (Oxford)200241121444144912468828
   PubMed Web of Science ®Google Scholar
• MindenKAdult outcomes of patients with JIAHorm Res200972Suppl 1202519940491
   PubMedGoogle Scholar
• RupertoNLevinsonJERavelliALong-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. I. Outcome statusJ Rheumatol19972459459519150087
   PubMed Web of Science ®Google Scholar
• WallaceCAHuangBBandeiraMRavelliAGianniniEHPatterns of clinical remission in select categories of JIAArthritis Rheum200552113554356216255044
   PubMed Web of Science ®Google Scholar
• HashkesPJLaxerRMMedical treatment of JIAJAMA2005294131671168416204667
   PubMed Web of Science ®Google Scholar
• GianniniEHBrewerEJKuzminaNMethotrexate in resistant juvenile rheumatoid arthritis. Results of the USA-USSR. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children’s Study GroupN Engl J Med199232616104310491549149
   PubMed Web of Science ®Google Scholar
• RupertoNMurrayKJGerloniVA randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with JIA who failed to respond to standard doses of methotrexateArthritis Rheum20045072191220115248217
   PubMed Web of Science ®Google Scholar
• LovellDJGianniniEHReiffAEtanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study GroupN Engl J Med20003421176376910717011
   PubMed Web of Science ®Google Scholar
• RupertoNLovellDJCutticaRA randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritisArthritis Rheum20075693096310617763439
   PubMed Web of Science ®Google Scholar
• LovellDJRupertoNGoodmanSAdalimumab with or without methotrexate in juvenile rheumatoid arthritisN Engl J Med2008359881082018716298
   PubMed Web of Science ®Google Scholar
• RingoldSSeidelKDKoepsellTDWallaceCAInactive disease in polyarticular JIA: Current patterns and associationsRheumatology (Oxford)200948897297719535609
   PubMed Web of Science ®Google Scholar
• LovellDJReiffAIlowiteNTSafety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritisArthritis Rheum20085851496150418438876
   PubMed Web of Science ®Google Scholar
• HashkesPJUzielYLaxerRMThe safety profile of biologic therapies for JIANat Rev Rheumatol201061056157120808294
   PubMed Web of Science ®Google Scholar
• MacaubasCNguyenKMilojevicDParkJLMellinsEDOligoarticular and polyarticular JIA: Epidemiology and pathogenesisNat Rev Rheumatol200951161662619806151
   PubMed Web of Science ®Google Scholar
• NistalaKWedderburnLRTh17 and regulatory T cells: Rebalancing pro- and anti-inflammatory forces in autoimmune arthritisRheumatology (Oxford)200948660260619269955
   PubMed Web of Science ®Google Scholar
• PrakkenBJAlbaniSUsing biology of disease to understand and guide therapy of JIABest Pract Res Clin Rheumatol200923559960819853826
   PubMed Web of Science ®Google Scholar
• HerveyPSKeamSJAbataceptBioDrugs2006201536116573350
   PubMed Web of Science ®Google Scholar
• GoebVBuchMHVitalEMEmeryPCostimulation blockade in rheumatic diseases: Where we are?Curr Opin Rheumatol200921324425019342956
   PubMed Web of Science ®Google Scholar
• GracaLCTLA4Ig and the therapeutic potential of T cell co-stimulation blockadeActa Reumatol Port2008333267276 [Portuguese].18846007
   PubMed Web of Science ®Google Scholar
• GenoveseMCSchiffMLuggenMEfficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapyAnn Rheum Dis200867454755417921185
   PubMed Web of Science ®Google Scholar
• Orencia® [Package insert]Princeton, NJBristol-Myers Squibb Company82009
   Google Scholar
• BruceSPBoyceEGUpdate on abatacept: A selective costimulation modulator for rheumatoid arthritisAnn Pharmacother20074171153116217609234
   PubMed Web of Science ®Google Scholar
• RupertoNLovellDJQuartierPAbatacept in children with JIA: A randomised, double-blind, placebo-controlled withdrawal trialLancet2008372963638339118632147
   PubMed Web of Science ®Google Scholar
• GianniniEHRupertoNRavelliALovellDJFelsonDTMartiniAPreliminary definition of improvement in juvenile arthritisArthritis Rheum1997407120212099214419
   PubMed Web of Science ®Google Scholar
• RupertoNLovellDJQuartierPPaediatric Rheumatology International Trials Organization and the Pediatric Rheumatology Collaborative Study GroupLong-term safety and efficacy of abatacept in children with juvenile idiopathic arthritisArthritis Rheum20106261792180220191582
   PubMed Web of Science ®Google Scholar
• RupertoNLovellDJLiTAbatacept improves health-related quality of life, pain, sleep quality and daily participation in subjects with JIAArthritis Care Res (Hoboken)201062111542155120597110
   PubMed Web of Science ®Google Scholar
• RupertoNRavelliAPistorioACross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodologyClin Exp Rheumatol2001194 Suppl 23S1S911510308
   PubMed Web of Science ®Google Scholar
• DurmoqiczELPediatric focused safety review FDA [online]. Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/ucm193143.pdf. Accessed 2010 Dec 21.
   Google Scholar
• Kuemmerle-DeschnerJBBenselerSAbatacept in difficult-to-treat JIABiologics20082486587419707464
   PubMedGoogle Scholar
• UngarWJCostaVHancock-HowardRFeldmanBMLaxerRMCost-effectiveness of biologics in polyarticular-course JIA patients unresponsive to disease modifying anti-rheumatic drugsArthritis Care Res (Hoboken)201163111111920740607
   PubMed Web of Science ®Google Scholar
• ZulianFBalzarinMFalciniFAbatacept for severe anti-tumor necrosis factor alpha refractory JIA-related uveitisArthritis Care Res (Hoboken)201062682182520191477
   PubMed Web of Science ®Google Scholar
• KenawyNClearyGMewarDBeareNChandnaAPearceIAbatacept: A potential therapy in refractory cases of JIA-associated uveitisGraefes Arch Clin Exp Ophthalmol1052010 [Epub ahead of print].
   Web of Science ®Google Scholar
• EmeryPDurezPDougadosMImpact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: A clinical and imaging study of abatacept (the ADJUST trial)Ann Rheum Dis201069351051619933744
   PubMed Web of Science ®Google Scholar
• RavelliAIoselianiMNorambuenaXAdapted versions of the Sharp/van der Heijde score are reliable and valid for assessment of radiographic progression in JIAArthritis Rheum20075693087309517763418
   PubMed Web of Science ®Google Scholar
• KeystoneECKremerJMRussellASSwitching patients with rheumatoid arthritis (RA) from intravenous (IV) to subcutaneous (SC) abatacept is well tolerated and sustains previously established efficacy [Abstract]Arthritis Rheum20106210 SupplS176
   Google Scholar
• HinksAWorthingtonJThomsonWThe association of PTPN22 with rheumatoid arthritis and JIARheumatology (Oxford)200645436536816418195
   PubMed Web of Science ®Google Scholar
• LeeYHRhoYHChoiSJThe PTPN22 C1858T functional polymorphism and autoimmune diseases – a meta-analysisRheumatology (Oxford)2007461495616760194
   PubMed Web of Science ®Google Scholar
• ThompsonSDSudmanMRamosPSThe susceptibility loci JIA shares with other autoimmune diseases extend to PTPN2, COG6, and ANGPT1Arthritis Rheum201062113265327620722033
   PubMed Web of Science ®Google Scholar
• GregersenPKLeeHSBatliwallaFBegovichABPTPN22: Setting thresholds for autoimmunitySemin Immunol200618421422316731003
   PubMed Web of Science ®Google Scholar